# Legend Capital's Biotech Investments: 24 Startups in Its Portfolio (2026) > The 24 Biotech startups Legend Capital has backed, by stage: $1.8B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/legend-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 11 - [Haihe Biopharma](https://millionrounds.com/company/haihe-biopharma) - [Harbour BioMed](https://millionrounds.com/company/harbour-biomed) - [*ED* Enjoy Dental Clinic](https://millionrounds.com/company/enjoy-dental-clinic) - [Medilink Therapeutics](https://millionrounds.com/company/medilink-therapeutics) - [*D* dMed](https://millionrounds.com/company/dmed) - [*B* Bellen](https://millionrounds.com/company/bellen) - [ColorTech Bio](https://millionrounds.com/company/colortech-bio) - [*YC* Yosemite Clinic](https://millionrounds.com/company/yosemite-clinic) - [*ZP* Zhejian POCtech](https://millionrounds.com/company/zhejian-poctech) - [Delova Biotech](https://millionrounds.com/company/delova-biotech) - [Percans Oncology](https://millionrounds.com/company/percans-oncology) ## Series C and later 8 - [Innovent Biologics](https://millionrounds.com/company/innovent-biologics) - [*SC* Shanghai Cell Therapy](https://millionrounds.com/company/shanghai-cell-therapy) - [*I* Innovent](https://millionrounds.com/company/innovent) - [New Horizon Health](https://millionrounds.com/company/new-horizon-health) - [Shanghai Cell Therapy Group](https://millionrounds.com/company/shanghai-cell-therapy-group) - [Sciwind Biosciences](https://millionrounds.com/company/sciwind-biosciences) - [LYNK Pharmaceuticals](https://millionrounds.com/company/lynk-pharmaceuticals) - [*A* Axionics](https://millionrounds.com/company/axionics) ## Stage not reported 3 - [Immunochina](https://millionrounds.com/company/immunochina) - [Berry Genomics](https://millionrounds.com/company/berry-genomics) - [Singlomics](https://millionrounds.com/company/singlomics) ## Pre-seed and seed 2 - [*LK* Lingtai Krypton Biotechnology](https://millionrounds.com/company/lingtai-krypton-biotechnology) - [N1 Life](https://millionrounds.com/company/n1-life) ## Segment by segment ### Series B 11 startups · $809M raised - [**Haihe Biopharma**](https://millionrounds.com/company/haihe-biopharma) Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs. China $317M - [**Harbour BioMed**](https://millionrounds.com/company/harbour-biomed) Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology. China $190M - [*ED* **Enjoy Dental Clinic**](https://millionrounds.com/company/enjoy-dental-clinic) China $70M - [**Medilink Therapeutics**](https://millionrounds.com/company/medilink-therapeutics) MediLink Therapeutics, founded in 2020 and based in Suzhou, China, is a clinical-stage biotechnology company focused on developing China $70M - [*D* **dMed**](https://millionrounds.com/company/dmed) China $50M - [*B* **Bellen**](https://millionrounds.com/company/bellen) China $38M - [**ColorTech Bio**](https://millionrounds.com/company/colortech-bio) ColorTech Bio researches and develops precision molecular diagnostic equipment. China $24M - [*YC* **Yosemite Clinic**](https://millionrounds.com/company/yosemite-clinic) Yosemite Clinic is a full-service clinic providing convinient walk-in medical services in a state-of-the-art enviroment in Central Pudong. China $15M ### Series C and later 8 startups · $984M raised - [**Innovent Biologics**](https://millionrounds.com/company/innovent-biologics) Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for China $385M - [*SC* **Shanghai Cell Therapy**](https://millionrounds.com/company/shanghai-cell-therapy) China $176M - [*I* **Innovent**](https://millionrounds.com/company/innovent) Hong Kong SAR China $150M - [**New Horizon Health**](https://millionrounds.com/company/new-horizon-health) New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes. China $96M - [**Shanghai Cell Therapy Group**](https://millionrounds.com/company/shanghai-cell-therapy-group) Shanghai Cell Therapy Group is an innovative company based in China, founded in 2013. China $77M - [**Sciwind Biosciences**](https://millionrounds.com/company/sciwind-biosciences) Sciwind Biosciences is a drug research and development company for metabolic diseases. China $70M - [**LYNK Pharmaceuticals**](https://millionrounds.com/company/lynk-pharmaceuticals) LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines. - $17M - [*A* **Axionics**](https://millionrounds.com/company/axionics) United States $15M ### Stage not reported 3 startups · $32M raised - [**Immunochina**](https://millionrounds.com/company/immunochina) Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development. China $20M - [**Berry Genomics**](https://millionrounds.com/company/berry-genomics) Berry Genomics is a Beijing-based company specializing in genomics and life sciences. China $10M - [**Singlomics**](https://millionrounds.com/company/singlomics) Singlomics uses single-cell sequencing technology for antibody drug discovery. China $1.4M ### Pre-seed and seed 2 startups · $24M raised - [*LK* **Lingtai Krypton Biotechnology**](https://millionrounds.com/company/lingtai-krypton-biotechnology) Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs. - $14M - [**N1 Life**](https://millionrounds.com/company/n1-life) N1 Life is a biotechnology research company based in Milpitas, California, founded in 2019 as a spinout from Stanford University. United States $10M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Legend Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Legend Capital's AI portfolio** 13 startups · $26B](https://millionrounds.com/portfolio-maps/legend-capital-ai-portfolio)[Portfolio map **Legend Capital portfolio map** 91 startups · $39B](https://millionrounds.com/portfolio-maps/legend-capital-portfolio-map)[Co-investors **Who invests with Legend Capital** 53 co-investors](https://millionrounds.com/portfolio-maps/legend-capital-co-investors)[Sector portfolio **Tengxun Touzi's AI portfolio** 42 startups · $42B](https://millionrounds.com/portfolio-maps/tengxun-touzi-ai-portfolio)[Sector portfolio **LD Capital's Web3 & Crypto portfolio** 41 startups · $292M](https://millionrounds.com/portfolio-maps/xie-web3-crypto-portfolio)[Sector portfolio **Tengxun Touzi's Fintech portfolio** 35 startups · $10B](https://millionrounds.com/portfolio-maps/tengxun-touzi-fintech-portfolio) ## Raising from investors like Legend Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)